Skip to main content
. 2020 Jul 22;20:684. doi: 10.1186/s12885-020-07176-7

Table 3.

Distribution of adverse events among study participants

All
(n = 49), n (%)
Good
(n = 27), n (%)
Poor
(n = 22), n (%)
All G 1/2 ≥G 3 All G 1/2 ≥G 3 All G 1/2 ≥G 3
Fatigue 4 (8) 4 (8) 0 2 (7) 2 (7) 0 2 (9) 2 (9) 0
Pruritis 3 (6) 3 (6) 0 3 (11) 3 (11) 0 0 0 0
Diarrhoea 6 (12) 3 (6) 3 (6) 2 (7) 0 2 (7) 4 (18) 3 (14) 1 (5)
Anorexia 2 (4) 2 (4) 0 1 (4) 1 (4) 0 1 (5) 1 (5) 0
Hypothyroidism 2 (4) 2 (4) 0 1 (4) 1 (4) 0 1 (5) 1 (5) 0
Rash 3 (6) 2 (4) 1 (2) 3 (11) 2 (7) 1 (4) 0 0 0
Hyperglycaemia 1 (2) 0 1 (2) 1 (4) 0 1 (4) 0 0 0
Liver dysfunction 1 (2) 1 (2) 0 0 0 0 1 (5) 1 (5) 0
Adrenal insufficiency 2 (4) 2 (4) 0 2 (7) 2 (7) 0 0 0 0
Stomatitis 1 (2) 1 (2) 0 1 (4) 1 (4) 0 0 0 0
Fever 1 (2) 1 (2) 0 1 (4) 1 (4) 0 0 0 0